Login / Signup

Astaxanthin Augmented the Anti-Hepatocellular Carcinoma Efficacy of Sorafenib Through the Inhibition of the JAK2/STAT3 Signaling Pathway and Mitigation of Hypoxia within the Tumor Microenvironment.

Pengfei RenQing-Juan TangXinjia HeJie XuYu-Ming WangChanghu Xue
Published in: Molecular nutrition & food research (2023)
The results suggest that AST supplement enhances the inhibitory effects of sorafenib on hepatocellular carcinoma. This study presents a new dietary management program for oncology patients.
Keyphrases
  • signaling pathway
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • climate change
  • peritoneal dialysis
  • oxidative stress
  • cell proliferation